Clinical Evaluation of Adjuncts to Opioid Therapies for the Treatment of Chronic Pain (R01)

Funding Opportunity PAR-14-225 from the NIH Guide for Grants and Contracts. This announcement aims to fund applications designed to assess the clinical value of adjuncts prescribed to chronic pain patients together with opioid analgesics. Adjuncts of interest are either approved by the FDA or have previously been studied as an Investigational New Drug. Studies with adjuncts of interest should be focused on enhancing analgesia, rather than on reducing an adverse effect. A secondary purpose is to increase awareness among opioid prescribers of the potential value of adjunctive therapies by focused data dissemination.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding